Veerappan Muthukkaruppan

Last updated

Veerappan Muthukkaruppan or VR. Muthukaruppan, also known as Dr. VRM, is an Indian immunologist. He worked for more than three decades as a professor of immunology at Madurai Kamaraj University. His primary research interests have been in the creation of potential vaccines and the use of purified porine for the diagnosis of murine typhoid, for which he has also created a number of monoclonal antibodies. Muthukkaruppan has researched the pathogenesis of Eales disease while attending Madurai Kamaraj University in association with Aravind Eye Hospital in Madurai. [1] As a result, he accepted an invitation to become the Aravind Medical Research Foundation's Director of Research in 1999 and to set up a lab for fundamental studies on eye illnesses. His research interests include the discovery of unique markers for human corneal epithelial stem cells, the immunology and aetiology of ocular inflammation linked to leptospirosis, the prevention of posterior capsular opacification, and the pathogenic mechanisms underlying diabetic retinopathy and Eales disease. From 1994 until 1997, Muthukkaruppan served as the Vice-Chancellor of Tamil Nadu's Bharathidasan University. The Indian Immunology Society elected him as its President from 1981 to 1982. [2] [3] [4]

Contents

Veerappan Muthukkaruppan
Born
Tamil Nadu, India
Nationality Indian
Alma mater
Awards
Scientific career
Fields
Institutions

Career

Investigative Ophthalmology and Visual Sciences' front cover features a photo from Muthukkaruppan's doctoral dissertation on the phenomenon of lens induction and differentiation in vitro . This famous discovery, which is still highly important to his current study on eye problems, is also mentioned in textbooks on developmental biology.[ citation needed ] With funding from the National Institutes of Health in the United States, he has launched a significant research programme at Annamalai University to investigate the growth and operation of the lizard's immune system. A chapter of this ground-breaking work was also included in Treatise on Reticuloendothelial System. His primary areas of study interest were thereafter typhoid and leprosy immunology. He proved the impairment of the alternative pathway (CD2) of T-cell activation and the mechanism of T-cell anergy using recombinant Mycobacterium leprae proteins in the polar form (lepromatous leprosy) of leprosy based on his experiments using well-defined leprosy patient samples. Using anti-porin monoclonal antibodies he has created, he has demonstrated the significance of porin (an outer membrane) as a prospective vaccine and in the diagnosis of typhoid disease in the mouse typhoid model. He created the mouse corneal model while a visiting professor at the University of Wisconsin. This work resulted in papers in Science and the Journal of the National Cancer Institute , as well as The American Journal of Pathology's cover image. [2] [5]

Awards and honours

Muthukkaruppan has received the Swami Pranavananda Award, the National Institute of Immunology Award (for the year 1992) for Senior Scientists and the Ranbaxy Research Award (for the year 1989). A National Fellow of the University Grants Commission (from 1986 to 1988), in 1990, Muthukaruppan was also elected as a Fellow of the Indian Academy of Sciences, Bangalore. [2] [5] [6]

Related Research Articles

In biology, immunity is the state of being insusceptible or resistant to a noxious agent or process, especially a pathogen or infectious disease. Immunity may occur naturally or be produced by prior exposure or immunization.

<span class="mw-page-title-main">Madurai Kamaraj University</span> Public state university in Tamil Nadu, India

Madurai Kamaraj University (MKU) is a public state university located in Madurai city, in southern Tamil Nadu, India, that was established in 1966. MKU is one of the 15 universities in India with the University with Potential for Excellence status, which was awarded by the University Grants Commission (UGC) in India. In 2021, the university was awarded an 'A++' grade from the National Assessment and Accreditation Council (NAAC) in its 4th cycle.

Immunogenicity is the ability of a foreign substance, such as an antigen, to provoke an immune response in the body of a human or other animal. It may be wanted or unwanted:

Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. It is recommended for infants at high-risk for RSV due to conditions such as prematurity or other medical problems including heart or lung diseases.

<span class="mw-page-title-main">Antonio Lanzavecchia</span> Italian and Swiss immunologist

Antonio Lanzavecchia is an Italian and Swiss immunologist. As a fellow of Collegio Borromeo he obtained a degree with honors in Medicine in 1976 from the University of Pavia where he specialized in Pediatrics and Infectious Diseases. He is Head Human Immunology Program, Istituto Nazionale di Genetica Molecolare-INGM, Milan and SVP Senior research Fellow, Humabs/Vir Biotechnology, Bellinzona and San Francisco (USA). Since 2017, he is also Professor at the Faculty of Biomedical Sciences of the Università della Svizzera italiana (USI).

The Sir William Dunn School of Pathology is a department within the University of Oxford. Its research programme includes the cellular and molecular biology of pathogens, the immune response, cancer and cardiovascular disease. It teaches undergraduate and graduate courses in the medical sciences.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

Barton Ford Haynes is an American physician and immunologist internationally recognized for work in T-cell immunology, retrovirology, and HIV vaccine development. Haynes is a Frederic M. Hanes Professor of Medicine and Immunology at Duke University Medical Center. He is the director of the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012. In addition, Haynes directs the B-cell Lineage Envelope Design Study, the Centralized Envelope Phase I Study, and the Role of IgA in HIV-1 Protection Study as part of the Collaboration for AIDS Vaccine Discovery (CAVD), which was funded by the Bill and Melinda Gates Foundation in 2006.

Perumalsamy Namperumalsamy is an Indian ophthalmologist who specializes in diabetic retinopathy. He is also a retina-vitreous expert. Namperumalsamy is currently the chairman Emeritus of Aravind Eye Hospital, Madurai. He is known for bringing assembly-line efficiency to eye surgery. In 2010, TIME magazine named Namperumalsamy one of the 100 most influential people in the world.

Gustav Gaudernack is a scientist working in the development of cancer vaccines and cancer immunotherapy. He has developed various strategies in immunological treatment of cancer. He is involved in several ongoing cellular and immuno-gene therapeutic clinical trials and his research group has put major efforts into the development of various T cell-based immunotherapeutic strategies.

Indira Nath was an Indian immunologist. Her major contribution in medical science deals with mechanisms underlying immune unresponsiveness in man, reactions and nerve damage in leprosy and a search for markers for viability of the Leprosy bacillus. Prof. Nath's fields of specialisations are Immunology, Pathology, Medical biotechnology, and communicable diseases.

Dorairajan Balasubramanian, popularly known as Professor Balu, is an Indian biophysical chemist and ocular biochemist. He is a former President of Indian Academy of Sciences and a director of research at the Prof. Brien Holden Eye Research Centre of L. V. Prasad Eye Institute, Hyderabad. A recipient of the National Order of Merit (France), Balasubramanian was honored by the Government of India, in 2002, with the fourth highest Indian civilian award of Padma Shri

<span class="mw-page-title-main">Edward Thomas Ryan</span>

Edward Thomas Ryan is an American microbiologist, immunologist, and physician at Harvard University and Massachusetts General Hospital. Ryan served as president of the American Society of Tropical Medicine and Hygiene from 2009 to 2010. Ryan is Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, Professor of Medicine at Harvard Medical School, and Director of Global Infectious Diseases at the Massachusetts General Hospital. Ryan's research and clinical focus has been on infectious diseases associated with residing in, immigrating from, or traveling through resource-limited areas. Ryan is a Fellow of the American Society of Microbiology, the American Society of Tropical Medicine and Hygiene, the American College of Physicians, and the Infectious Diseases Society of America.

<span class="mw-page-title-main">Holger Lode</span> German specialist for pediatrics (born 1967)

Holger Lode is a German specialist for pediatrics. He is Professor and Chair of the Department of General Pediatrics and Pediatric Hematology and Oncology at the University Medicine Greifswald. He is also the director of the Center of Pediatrics and Adolescent Medicine in Greifswald. Lode is well known for his clinical and scientific work on immunotherapy of neuroblastoma.

Kuppamuthu Dharmalingam is an Indian proteomicist, geneticist, academic and the founder of Centre of Excellence in Bioinformatics at Madurai Kamaraj University. He is known for his contributions in the fields of eye disease proteomics and mutagenic DNA repair in Escherichia coli. He is an elected fellow of the Indian Academy of Sciences and the National Academy of Sciences, India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 1992, for his contributions to biological sciences.

Gopal Dhinakar Raj is an Indian veterinary scientist, an academic and the project director of the Translational Research Platform for Veterinary Biologicals, a partnership program between the Department of Biotechnology and the Tamil Nadu Veterinary and Animal Sciences University. Known for the development of diagnostic test kits for animal and poultry diseases such as Leptospirosis and Egg drop syndrome, Raj is a member of the DBT Task Force on Animal Biotechnology. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2007.

<span class="mw-page-title-main">Nancy Sullivan (biologist)</span> American cell biologist

Nancy Jean Sullivan is an American cell biologist researching filovirus immunology and vaccine development. She is a senior investigator and chief of the biodefense research section at the Vaccine Research Center. Her team discovered the monoclonal antibody, mAb114.

<span class="mw-page-title-main">Weatherall Institute of Molecular Medicine</span>

The MRC Weatherall Institute of Molecular Medicine at the University of Oxford is a research institute located at the John Radcliffe Hospital in Oxford. Founded in 1989 by Sir David Weatherall, the institute focuses on furthering our understanding of clinical medicine at a molecular level. It was one of the first institutes of its kind in the world to be dedicated to research in this area.

Shabaana A. Khader is an Indian-American microbiologist who is the Bernard and Betty Roizman Professor of Microbiology at the University of Chicago. She is also the Chair of the Department of Microbiology. In an effort to design new vaccines and therapeutic strategies, Khader studies host-pathogen interactions in infectious disease.

R. M. Pitchappan or Ramasamy Pitchappan, Ph.D., F.A.Sc., F.A.M.S., is an Indian biologist known for his studies on immunogenetics and infectious diseases. He was a professor in the School of Biological Sciences (SBS) of the Madurai Kamaraj University (MKU). In addition, Pitchappan held the positions of director, Educational Medical Research Centre, director-research, Chettinad University, Chennai, and adjunct professor, ICMR Andaman Nicobar Islands. He also held the position of the vice-president of the Nilgiri Adivasi Welfare Association in Kotagiri, Nilgiris, and as an advisor to the ancient DNA programme of Government of Tamil Nadu.

References

  1. ↑ "Prof. Muthukkaruppan". Aravind Eye Care System. Retrieved 3 May 2013.
  2. 1 2 3 "Indian Fellow". Indian National Science Academy . Retrieved 3 May 2013.
  3. ↑ "School of Biological Sciences, Madurai Kamaraj University, Madurai" (PDF). School of Biological Sciences, Madurai Kamaraj University, Madurai. Retrieved 3 May 2013.
  4. ↑ Rao, Kanury V S. (2008). "Immunology in India: an emerging story". Nature Immunology. 9 (12): 1319–1322. doi: 10.1038/ni1208-1319 . PMID   19008927. S2CID   13578158 . Retrieved 3 May 2013.
  5. 1 2 "Prof. Muthukkaruppan". Aravind Eye Care System. Retrieved 3 May 2013.
  6. ↑ "Prof. Veerappan Muthukkaruppan Ph.D. (Wisconsin), FNA". Indian Academy of Sciences . Retrieved 3 May 2013.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.